Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-055823
Filing Date
2015-08-04
Accepted
2015-08-04 15:30:12
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-11889_110q.htm 10-Q 1285725
2 EX-31.1 a15-11889_1ex31d1.htm EX-31.1 19059
3 EX-31.2 a15-11889_1ex31d2.htm EX-31.2 19108
4 EX-32.1 a15-11889_1ex32d1.htm EX-32.1 9040
  Complete submission text file 0001104659-15-055823.txt   7477365

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnta-20150630.xml EX-101.INS 2094326
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnta-20150630.xsd EX-101.SCH 60207
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnta-20150630_cal.xml EX-101.CAL 47000
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mnta-20150630_lab.xml EX-101.LAB 503948
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnta-20150630_pre.xml EX-101.PRE 303313
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnta-20150630_def.xml EX-101.DEF 167273
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50797 | Film No.: 151025264
SIC: 2836 Biological Products, (No Diagnostic Substances)